Urodynamic study
Diagnostic Testcomparison between the urodynamic study of the patients before pelvic prolapse surgical repair and 6 months later.
NCT Number: NCT04793126
To assess the urinary symptoms and urodynamic findings concomitant with Pelvic organ prolapse before and after surgical treatment and to define the role of urodynamic study in treatment decision making.
Looking for future studies?
Notify MeFemale
Interventional
Phase 2
Pelvic organ prolapse (POP) is a prevalent problem that affects women's quality of life women with POP may present with a variety of lower urinary tract symptoms (LUTS).
For POP patients with concomitant urinary symptoms, urodynamic (UDN) testing is proposed for proper evaluation of cases and identification of the pathophysiologic events in each case individually.
In this prospective study, the investigators aim to describe the urinary symptoms and urodynamic findings concomitant with POP before and after surgical treatment of POP. We also aimed at defining the role of UDN in decision-making regarding the treatment of POP when associated with LUTS.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
comparison between the urodynamic study of the patients before pelvic prolapse surgical repair and 6 months later.
Time frame: 6 month after the procedure
evaluation of the urodynamic study after the surgical repair of the pelvic organ prolapse and comparison to the preoperative results.
Ain Shams University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02890498
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
Nîmes, France
View Trial DetailsNCT06532292
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
Taipei, Taiwan
View Trial DetailsNCT07554651
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Dnipro, Ukraine
View Trial DetailsNCT07552337
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
Diyarbakır, Turkey (Türkiye)
View Trial Details